When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JNJ - Subcutaneous formulation of J&J's Darzalex OK'd in Europe
Johnson & Johnson
As expected, the European Commission approves a subcutaneous fixed-dose formulation of Johnson & Johnson's (JNJ-1.1%) Darzalex (daratumumab) for the treatment of multiple myeloma.
More news on: Johnson & Johnson, Genmab A/S, Healthcare stocks news,